Debt-to-equity of Tevogen Bio Holdings Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Tevogen Bio Holdings Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
Tevogen Bio Holdings Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -151%, a 32% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Tevogen Bio Holdings Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	-151%	-37%	-32%	30 Sep 2025
Q2 2025	-154%	-85%	-123%	30 Jun 2025
Q1 2025	-153%	-102%	-201%	31 Mar 2025
Q4 2024	-155%	-111%	-252%	31 Dec 2024
Q3 2024	-114%	-92%	-399%	30 Sep 2024
Q2 2024	-69%	-38%	-123%	30 Jun 2024
Q1 2024	-51%	-3.4%	-7.2%	31 Mar 2024
Q4 2023	-44%	+35%	+44%	31 Dec 2023
Q3 2023	-23%	+83%	+78%	30 Sep 2023
Q2 2023	-31%	+76%	+71%	30 Jun 2023
Q1 2023	-48%			31 Mar 2023
Q4 2022	-79%			31 Dec 2022
Q3 2022	-106%			30 Sep 2022
Q2 2022	-107%			30 Jun 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.